Roche withdraws submission for Avastin

28 March 2017 - Roche was seeking a positive CADTH recommendation for the use of bevacizumab in combination with pemetrexed ...

Read more →

AbbVie withdraws submission for Venclexta

10 January 2017 - Abbvie was seeking funding for venetoclax when used as a treatment for patients with chronic lymphocytic ...

Read more →